ONCOLOGY CONTRACT 
MANUFACTURING

At Baxter’s manufacturing facility dedicated to oncology products in Halle/Westfalen, Germany, all of your parenteral needs are handled at one location, enabling processing solutions to fit your compound.

Your oncology products can make a difference in patients’ lives. 

Our oncology manufacturing expertise can help you make that difference.

Global Experience

More than 60 years of oncology experience manufacturing products sold worldwide including North America, South America, Europe and Asia.

Broad Expertise

Dedicated clinical through commercial production with integrated technologies and services. Specialized areas of focus include cytotoxics, highly potent compounds, biologics, lyophilized products, and antibody-drug conjugates (ADCs).

Maximizing Manufacturing Value

Baxter’s Halle facility offers state-of-the-art cGMP manufacturing, uniquely designed to deliver high-quality products with optimum efficiency and speed to market.

To discuss sterile contract manufacturing services for injectable molecules, please contact us at: 
United States: 1-800-4-BAXTER 
International: 1-224-948-4770

Go to article: Home | Time for UK plasma to shineGo to article: In this issueGo to article: ContentsGo to article: DatwylerGo to article: LabcorpGo to article: UPS Healthcare Company InsightGo to article: UPS Healthcare Go to article: BaxterGo to article: SHL MedicalGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: PerkinElmerGo to article: CommentGo to article: A new day for Alzheimer’s disease treatmentGo to article: Covid-19 vaccine inequity: the debate over patent waivers intensifiesGo to article: Covid-19 vaccines show efficacy in adolescentsGo to article: International pharmacovigilance for biotechs: forming a strategyGo to article: NiproGo to article: HOF SonderanlagenbauGo to article: MyonexGo to article: In DepthGo to article: Malaria vaccines through the agesGo to article: Are competition authorities tightening the rules on pharma M&A? Go to article: The fishy business of shark squaleneGo to article: Without a trace: can pharma reduce scarring?Go to article: Blood plasma production: OK for the UK?Go to article: When the drugs don’t work: can pharma keep up with mental health?Go to article: The Solubility Company - Company Insight Go to article: The Solubility companyGo to article: Owen Mumford Company InsightGo to article: Owen MumfordGo to article: In DataGo to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue